According to a study investigating the medication use patterns in IBD patients based on data from a nationwide administrative claims-based database of the NHIS in South Korea, 5-aminosalicylic acid was most commonly used, followed by corticosteroids, immunomodulators, and anti-TNF-α agent [20]. The gene discussed is TNF; the disease is inflammatory bowel disease.